Brief reportsEffectiveness of Inhibition of Cholesteryl Ester Transfer Protein by JTT-705 in Combination With Pravastatin in Type II Dyslipidemia
References (10)
- et al.
A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol
J Lipid Res
(1978) - et al.
Purification, microheterogeneity, and stability of human lipid transfer protein
J Biol Chem
(1989) - et al.
Secretion of pre beta HDL increases with the suppression of cholesteryl ester transfer protein in HepG2 cells
Atherosclerosis
(1999) - et al.
Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits
J Biol Chem
(1998) - et al.
Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study
Circulation
(2002)
There are more references available in the full text version of this article.
Cited by (176)
Cholesteryl ester transfer protein inhibitors in precision medicine
2020, Clinica Chimica ActaHDL and Endothelium
2018, Endothelium and Cardiovascular Diseases: Vascular Biology and Clinical SyndromesReverse Cholesterol Transport in HDL Metabolism: Relevance to Atherosclerosis Progression and Cardiovascular Diseases
2017, The HDL Handbook: Biological Functions and Clinical Implications: Third EditionTargeting High-density Lipoproteins to Reduce Cardiovascular Risk: What Is the Evidence?
2015, Clinical TherapeuticsLearning by Experience: Examples of Translational Processes in the Cardiovascular Field
2015, Principles of Translational Science in Medicine: From Bench to Bedside: Second EditionHDL Metabolism and Atheroprotection. Predictive Value of Lipid Transfers
2014, Advances in Clinical Chemistry
This study was supported by a grant from AKROS Pharma Inc., Princeton, New Jersey. Dr. Klerkx was supported by a grant from the Dutch Heart Foundation, Amsterdam, The Netherlands (NHS 2000.073 and NHS 2003B191).
Copyright © 2005 Excerpta Medica Inc. All rights reserved.